Skip to main content
Circa Group AS logo

Circa Group AS — Investor Relations & Filings

Ticker · CIRCA ISIN · NO0010917594 LEI · 549300TYMT7PQV920R92 OL Manufacturing
Open in API
Filings indexed 376 across all filing types
Latest filing 2022-03-02 Earnings Release
Country NO Norway
Listing OL CIRCA

About Circa Group AS

https://circa-group.com/

Circa Group AS is a renewable chemicals company that develops and commercializes bio-based products. It utilizes a proprietary thermochemical process, Furacell™, to convert non-food, waste cellulosic biomass into advanced biochemicals. The company's portfolio is centered on the platform chemical levoglucosenone (LGO) and its derivatives, most notably the bio-based solvent Cyrene™. Cyrene™ is designed as a safer, more sustainable alternative to traditional, fossil-derived polar aprotic solvents like NMP. Circa aims to produce these biochemicals at an industrial scale, serving various markets, including pharmaceuticals, agrochemicals, and specialty polymers, that are transitioning to greener chemistry. The company is scaling up its manufacturing capabilities through its ReSolute plant project.

Recent filings

Filing Released Lang Actions
Q4 RESULTATER - POSITIV TEKNISK OG FINANSIELL UTVIKLING UNDERSTØTTER FREMDRIFTEN TIL CIRCA
Earnings Release Classification · 100% confidence The document is titled 'Q4 RESULTATER' (Q4 RESULTS) and discusses the financial and operational progress for the fourth quarter, including updates on the ReSolute™ factory, government support, and market acceptance. This content strongly indicates an announcement of periodic financial results. Since it is a summary announcement (implied by the short length and the mention of an accompanying webinar to review the summary), it fits the definition of an Earnings Release (ER). It is not the full Annual Report (10-K) or a comprehensive Interim Report (IR), but rather the initial release of period results. Q4 2021
2022-03-02 Norwegian
Q4 RESULTS - POSITIVE TECHNICAL AND FINANCIAL DEVELOPMENTS UNDERPIN CIRCA PROGRESS
Earnings Release Classification · 98% confidence The document explicitly states it is announcing its "fourth quarter results" and uses the headline "Q4 RESULTS". This strongly indicates a periodic financial performance announcement. Given the short length (3920 chars) and the immediate mention of a webinar to discuss the summary, it aligns best with an Earnings Release (ER), which provides key highlights before a full quarterly report (IR) or a management discussion (MDA). It is not a full annual report (10-K) or a comprehensive interim report (IR), but rather the initial announcement of the period's results. Q4 2021
2022-03-02 English
Corrected Timing for Publication of Q4 Results and Webinar
Report Publication Announcement Classification · 98% confidence The document text is very short (282 characters) and explicitly announces the corrected timing for the publication of Q4 results and a subsequent webinar. This fits the definition of announcing the release or timing of a report rather than being the report itself. This aligns best with the Report Publication Announcement (RPA) category, which covers announcements regarding the timing or release of company reports.
2022-03-01 English
CIRCA GROUP ANNOUNCES PRICE INCREASES FOR LEVOGLUCOSENONE AND BIO-SOLVENT CYRENE™
Regulatory Filings Classification · 100% confidence The document is explicitly titled 'PRESS RELEASE' and announces specific business actions: price increases for Levoglucosenone and Cyrene™. It includes commentary from the CEO, background information about the company and its products, and contact details for investors and media. This format is characteristic of an Earnings Release (ER) or a general corporate announcement. Since it is not a full financial report (like 10-K or IR), nor a transcript (CT), nor a specific regulatory filing like DIRS or DIV, the most appropriate classification for a press release detailing operational/pricing updates is Earnings Release (ER), as these often accompany or precede formal earnings reports, or serve as standalone material updates. Given the content focuses on pricing and business strategy rather than just financial figures, it could also be considered a Regulatory Filing (RNS) if it were a mandatory disclosure, but ER is a better fit for a 'Press Release' announcing commercial changes.
2022-02-28 English
CIRCA GROUP ANNOUNCES PRICE INCREASES FOR LEVOGLUCOSENONE AND BIO-SOLVENT CYRENE™
Regulatory Filings Classification · 100% confidence The document is a short announcement titled "CIRCA GROUP ANNOUNCES PRICE INCREASES FOR LEVOGLUCOSENONE AND BIO-SOLVENT CYRENE™". It details specific price adjustments (25% for Levoglucosenone, 15% for Cyrene™) effective March 1, 2022, and provides commentary from the CEO. This type of announcement, focusing on pricing changes for specific products, does not fit neatly into the major financial reporting categories (10-K, IR, ER). It is a specific business update related to commercial operations and pricing strategy. Given the options, it is best classified as a general Regulatory Filing (RNS) as it is a material business announcement that doesn't match the more specific categories like Capital/Financing (CAP) or Earnings Release (ER). It is too specific for a general press release fallback, but RNS serves as the best fit for material, non-standard regulatory disclosures.
2022-02-28 English
CIRCA GROUP AS – INVITATION TO Q4 2021 RESULTS
Earnings Release Classification · 95% confidence The document is titled "PRESS RELEASE" and explicitly announces the publication date and time for the "Q4 2021 quarterly report and presentation." It also mentions a subsequent webinar for discussing the results. This structure—announcing the release of financial results and providing access details for the associated materials (report and presentation)—is characteristic of an Earnings Release (ER) or a Report Publication Announcement (RPA). Given the document's short length (2414 chars) and its primary function being to inform the market *when* the Q4 results will be available and to invite participation in a follow-up call, it fits the definition of an Earnings Release (ER) which is the initial announcement of periodical financial results (key highlights/summary context provided via the webinar invitation). While it announces the release of a report, the content itself is the announcement of the earnings event, making ER a strong fit, though RPA is also plausible. Since it specifically mentions the 'quarterly report' and 'presentation' release, ER is prioritized over the general RPA. Q4 2021
2022-02-25 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.